- Home
- Home
- Supplements
- Chromium Picolinate
Chromium Picolinate
Chromium Picolinate
TL;DR
Chromium picolinate is taken at 200–1000 mcg/day for blood sugar. Effects on HbA1c are small and inconsistent; benefit is largest in poorly controlled diabetes.
Ideal For
- People with poorly controlled type 2 diabetes, as an adjunct
- Those with insulin resistance and low dietary chromium
- People with carbohydrate cravings in atypical depression
- Adults on refined diets low in whole grains and broccoli
Avoid If
- You have kidney or liver disease
- You take insulin or sulfonylureas without glucose monitoring
- You expect it to replace diabetes medication
Frequently Asked Questions
Overview
Chromium is a trace mineral that appears to enhance insulin signalling, historically attributed to a chromium-containing oligopeptide once called glucose tolerance factor. Picolinate is the most studied supplemental form because chelation improves what is otherwise very poor absorption — under 2% of an oral dose.
The clinical literature is large and disappointing in a specific way. Meta-analyses of trials in type 2 diabetes find statistically significant but small reductions in fasting glucose and HbA1c, on the order of 0.3-0.5 percentage points, with substantial heterogeneity. Benefit clusters in people with poor baseline control and possibly with low chromium status; trials in well-controlled or non-diabetic participants show essentially nothing. Chromium is not a substitute for metformin or lifestyle change.
Two other threads deserve mention. Weight loss trials show an average difference of well under a kilogram, not clinically useful. Trials in atypical depression and binge eating at 600-1000 mcg/day have reported reductions in carbohydrate craving, which is a more interesting signal than the weight data. Safety at typical doses is good, though isolated case reports of kidney injury exist at very high intakes.
How It Works
- Enhances insulin receptor tyrosine kinase activity and downstream signalling
- Increases GLUT4 translocation to the muscle cell membrane
- May reduce insulin resistance most where chromium status is low
- Possible serotonergic effects underlying reduced carbohydrate craving
- Picolinate chelation improves absorption of an otherwise poorly absorbed mineral
Quick Facts
- Enhances insulin sensitivity
- Supports healthy blood sugar regulation
- May help reduce sugar cravings
- Important for macronutrient metabolism
- Picolinate form has superior absorption
Benefits & Outcomes
Carbohydrate Metabolism
Chromium yields small glucose improvements, concentrated in people with poor baseline control or genuine deficiency.
Blood Sugar Balance
Small, inconsistent glucose effects; not a reliable tool for glycaemic control.
Metabolic Flexibility
Chromium has been widely marketed for appetite and body composition with minimal supporting evidence.
Cholesterol Management
Lipid effects of chromium are small and not consistently reproduced.
Health Concerns Addressed
Hypoglycemia
Small trials from the 1980s-90s suggested chromium may blunt reactive hypoglycaemia by improving insulin efficiency, but the evidence is old, small and never replicated at quality. Meal composition changes work far more reliably — and in anyone on diabetes medication, glucose-lowering supplements raise hypoglycaemia risk.
Blood Sugar Dysregulation
Chromium produces small and inconsistent glycaemic improvements, with any real benefit likely confined to people with poor chromium status.
Excessive Appetite
Marketing outruns the data; appetite effects are small and inconsistent across trials.
Supporting Research10 studies
Chromium picolinate supplementation for overweight or obese adults
Tian H, Guo X, Wang X +3 more
Chromium produced a very small weight difference of uncertain clinical relevance and no reliable change in metabolic rate.
Chromium picolinate supplementation for overweight or obese adults
Tian H, Guo X, Wang X +4 more
Chromium picolinate produced a 1.1 kg greater weight loss than placebo, an effect of questionable clinical relevance and low-quality evidence.
Effects of chromium picolinate on food intake and satiety
Anton SD, Morrison CD, Cefalu WT +2 more
Study 1 demonstrated that CrPic, as compared to placebo, reduced food intake (P<0.0001), hunger
Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus
Yin RV, Phung OJ
Chromium supplementation produced small reductions in HbA1c and fasting plasma glucose versus placebo.
Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults
Iqbal N, Cardillo S, Volger S
CrPic at 1000 microg/day does not improve key features of the metabolic syndrome in obese nondiabetic patients.
Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial
Kleefstra N, Houweling ST, Bilo HJ
Chromium picolinate had no effect on HbA1c, insulin requirements, lipids or body weight in insulin-treated type 2 diabetes.
A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder (BEACh study)
Brownley KA, Von Holle A, Hamer RM +2 more
Fasting glucose was significantly reduced in both chromium groups compared to the placebo group
A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving
Docherty JP, Sack DA, Roffman M +1 more
113 adult outpatients with atypical depression were randomized 2:1 to receive 600 mug/day of elemental chromium, as provided by chromium picolinate (CrPic), or placebo
A meta-analysis of the effect of chromium supplementation on anthropometric indices of subjects with overweight or obesity
Tsang C, Taghizadeh M, Aghabagheri E +2 more
Chromium supplementation produced a small reduction in body weight and body fat percentage of doubtful clinical significance.
Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial
Amooee S, et al.
Overall, chromium picolinate was better tolerated compared to metformin; nonetheless, the two study groups were not significantly different regarding ovulation and pregnancy rates.
Safety Information
Potential Side Effects
Generally well tolerated. Headache, insomnia, irritability and gastrointestinal upset are reported. Rare case reports of kidney impairment and rhabdomyolysis at very high or prolonged doses.
Contraindications
Caution in renal or hepatic impairment given isolated case reports of injury at high doses. Additive glucose lowering with diabetes medication requires monitoring.
Drug Interactions
- Insulin and sulfonylureas — additive glucose lowering, monitor closely
- Levothyroxine — chromium reduces absorption; separate by at least 4 hours
- Antacids and proton pump inhibitors — reduce chromium absorption
- NSAIDs — may increase chromium absorption
Pregnancy & Breastfeeding
Pregnancy: insufficient_data
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
200-1000 mcg
Best Time to Take
With breakfast, or split across two meals
Best Form
Chromium picolinate, on absorption and evidence grounds
Bioavailability
Picolinate form has better absorption than chromium chloride. May enhance insulin sensitivity. Evidence for blood sugar benefits mixed. Can lower blood sugar - monitor if diabetic.
Forms Compared
Chromium picolinate
Chromium polynicotinate
Chromium chloride
Brewer's yeast chromium
Food & Timing
With meals — vitamin C improves absorption and food reduces occasional nausea
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.